The U.S. military has announced a program to begin testing service members’ testosterone levels and to offer testosterone replacement therapy (TRT) to those who meet clinical criteria. TRT is a synthetic form of the hormone designed for men with a medically confirmed deficiency. While some research shows benefits for patients who qualify, experts emphasize that the long-term risks and the appropriateness of TRT for men without a clear deficiency remain uncertain. The announcement comes as part of a broader national conversation about hormone therapies, performance, and aging, and as the military seeks to ensure service members operate at their best within medical safeguards.
Defense officials say the plan is to help troops perform under demanding conditions while ensuring treatment is limited to those with a validated need. The policy aligns with a wider push to expand access to hormone therapies, a trend fueled by private clinics and telehealth platforms, as well as political attention directed at public health options for hormone optimization. Prescription data show a sharp rise in TRT usage, with annual prescriptions climbing from about 7.3 million in 2019 to more than 11 million in 2024, according to IQVIA, a healthcare data company. Critics caution that TRT is not a universal remedy for fatigue or aging and warn against overuse, especially among men who have not been formally diagnosed with a deficiency.
Medical experts note that diagnosing testosterone deficiency is not based on a single test. Testosterone levels naturally decline with age, but that decline alone does not usually justify treatment. Sleep disorders, testicular injury, pituitary disorders, certain cancer treatments, and chronic illnesses can all suppress testosterone production. In some cases, clinicians diagnose functional hypogonadism, in which factors such as obesity or chronic disease cause lower testosterone levels even when reproductive organs are structurally normal. As NYU Langone Health endocrinologist Marcus Goncalves explained, addressing obesity, stress, fatigue, and sleep problems can help testosterone rebound, though restoring levels is not always straightforward. The process typically involves confirming low levels with two separate morning blood draws and evaluating potential underlying causes before considering therapy.
Physicians emphasize that not every low reading warrants treatment. Testosterone can fluctuate during the day and in response to stress, illness, weight loss, or exertion, and levels may return to normal once such factors resolve. University of Michigan internist Richard Auchus noted that it can be difficult to distinguish a reversible functional issue from a permanent deficiency. In general, clinicians aim to limit TRT to patients who are likely to benefit. When used appropriately, TRT can improve sex drive, erectile function, muscle mass, bone density, energy, and mood for those with a confirmed deficiency. It can also strengthen bone health, reducing osteoporosis risk in men with low hormone levels.
However, experts caution that raising testosterone in men with normal or mildly low levels offers unclear benefits for energy, cognition, or athletic performance, and the therapy remains controversial as an anti-aging or performance-enhancing measure. Dobs of Johns Hopkins Medicine stressed the importance of cautious, individualized use to avoid overreplacement. Risks include increases in red blood cell counts, which can thicken the blood and raise clot risks. Cardiovascular safety has been scrutinized; a landmark 2023 trial found no overall increase in heart attack, stroke, or cardiovascular death among men on TRT versus placebo, though it noted higher incidences of atrial fibrillation and kidney injury in the TRT group.
Fertility concerns are another consideration, since TRT can suppress natural testosterone production and reduce sperm production. This makes TRT generally less suitable for men who may want children. Other side effects can include acne, breast tenderness or enlargement, fluid retention, and worsened sleep apnea. Despite some earlier concerns, the latest evidence has been more reassuring on cardiovascular risk for many patients, but careful patient selection and monitoring remain essential.
Regarding the military context, experts say interpreting testosterone levels under extreme physical and psychological stress is complex. Intense training, sleep deprivation, and heavy exertion can temporarily lower testosterone. In a study of Marines undergoing SERE training, testosterone fell by about half during exercise before recovering afterward. While some researchers see value in studying TRT’s impact during deployment, others caution that restoring testosterone during such periods may not enhance performance. The possibility of dependence on therapy with long-term use also puts attention on continuity of care during deployments if access to TRT is interrupted.
Overall, officials and clinicians contend that TRT should not be viewed as a shortcut to improved military performance. Training, decision-making, and resilience remain central to effectiveness. Doctors stress careful patient selection, ongoing monitoring, and a clear understanding of individual risks and benefits as TRT becomes more prominent in public-health discussions. The topic continues to evolve as new data emerge about long-term safety, efficacy, and the role of TRT for different populations, including service members.
Source notes: The information reflects statements from defense officials and multiple medical experts regarding when TRT is appropriate, how deficiency is diagnosed, potential benefits and risks, and considerations for military applicability.
